US patent granted on therapeutic antibodies for Parkinson’s disease

The US patent office has granted BioArctic a US patent (US 8809506) covering therapeutic and diagnostic antibodies for Parkinson’s disease and Dementia with Lewy Bodies.

These antibodies are a novel type of antibodies binding and reducing α-synuclein protofibrils in the brain, and therefore of important therapeutic value, since α-synuclein protofibrils are believed to be central in the Parkinson disease process.